Targeting DNMT3B in multiple myeloma: a novel epigenetic-based targeting approach that displays potent anti-myeloma activity and enhances sensitivity to standard of care agents

Activiteit: Talk or presentation at a conference

Periode2 feb 2024
Evenementstitel39th General Annual Meeting of the Belgian Hematology Society 2024
EvenementstypeConference
Mate van erkenningInternational